Healius | HLS - Sales Revenues

Stock Price
0.53
Daily Change
0.02 2.94%
Monthly
-13.93%
Yearly
-62.50%
Q2 Forecast
0.51

Healius reported AUD688.1M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Alcidion AUD 25.47M 2.32M Dec/2025
Ansell USD 1.03B 192.2M Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 5.45B 470M Dec/2025